Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients

被引:10
|
作者
Burgos, JS [1 ]
Vera-Sempere, FJ
机构
[1] Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa,CV Lab 203, E-28049 Madrid, Spain
[2] Univ Valencia, Hosp La Fe, Sch Med, Serv Pathol, Valencia, Spain
来源
LARYNGOSCOPE | 2000年 / 110卷 / 12期
关键词
Epstein-Barr virus; nasopharyngeal carcinoma; non-isotopic in situ hybridization; PCR;
D O I
10.1097/00005537-200012000-00020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: The aim of this study was to analyze the relevance of the CD21 membrane receptor in nasopharyngeal carcinoma (NPC). CD21 is implicated in the introduction of the Epstein-Barr virus (EBV) genome into epithelial cells and B lymphocytes. Study Design: Immunohistochemical analysis of CD21 in NPC. Methods: Paraffin-embedded samples of NPC of different histological types with demonstrated presence of EBV were analyzed for CD21 expression using immunohistochemistry. Results: We detected EBV by non-isotopic in situ hybridization (NISH) and nested polymerase chain reaction (PCR) in 100% of samples, regardless of histological type, supporting the previous view that all the types of NPC are variants of an EBV-associated malignancy. CD21 was not detected in NPC, and this absence was a typical feature in our data group. Conclusions: The loss of the CD21 membrane receptor could be one of the immunophenotypical changes of the neoplastic cells that occur in the evolution of the NPC malignancy.
引用
收藏
页码:2081 / 2084
页数:4
相关论文
共 50 条
  • [11] The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells
    Lin, CT
    Lin, CR
    Tan, GK
    Chen, WS
    Dee, AN
    Chan, WY
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (05): : 1745 - 1756
  • [12] SUPERINFECTION OF EPITHELIAL NASOPHARYNGEAL CARCINOMA CELLS WITH EPSTEIN-BARR VIRUS
    GLASER, R
    THE, GD
    LENOIR, G
    HO, JHC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (03) : 960 - 963
  • [13] Detection of Epstein-Barr virus in nasopharyngeal carcinoma
    Hasegawa, M
    Kobayashi, R
    Okayasu, I
    Hirai, H
    E.R.S. & I.S.I.A.N. MEETING '98, 1998, : 323 - 326
  • [14] Nasopharyngeal carcinoma: Epstein-Barr virus significance
    Kottaridis, SD
    Panotopoulou, E
    Diamantis, I
    Goula, I
    Danilidis, J
    Fountzilas, G
    ANTICANCER RESEARCH, 1996, 16 (02) : 785 - 789
  • [15] Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma
    Robert B West
    Nature Genetics, 2014, 46 : 809 - 810
  • [16] Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma
    West, Robert B.
    NATURE GENETICS, 2014, 46 (08) : 809 - 810
  • [17] Impact of Epstein-Barr virus and CD lymphocytes on the prognosis of patients with advanced nasopharyngeal carcinoma
    Liu, Fangchu
    Peng, Yonghua
    Wang, Xintao
    Long, Weili
    Huang, Zhenhe
    INFECTIOUS AGENTS AND CANCER, 2025, 20 (01):
  • [18] Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma
    Tsiambas, Evangelos
    Mastronikolis, Nicholas S.
    Fotiades, Panagiotis P.
    Ragos, Vasileios
    Kavantzas, Nikolaos
    Lazaris, Andreas C.
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 1347 - 1348
  • [19] EPSTEIN-BARR VIRUS TRANSCRIPTION IN NASOPHARYNGEAL CARCINOMA
    RAABTRAUB, N
    HOOD, R
    YANG, CS
    HENRY, B
    PAGANO, JS
    JOURNAL OF VIROLOGY, 1983, 48 (03) : 580 - 590
  • [20] Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
    Hau, Pok Man
    Lung, Hong Lok
    Wu, Man
    Tsang, Chi Man
    Wong, Ka-Leung
    Mak, Nai Ki
    Lo, Kwok Wai
    FRONTIERS IN ONCOLOGY, 2020, 10